Recommendation ID
NG17/02
Question

The use of C-peptide in diagnosing diabetes: What is the effectiveness of C‑peptide at correcting misclassification of diabetes diagnosis and what is the optimal timing for the test in distinguishing subtypes of diabetes?

Any explanatory notes
(if applicable)

For a short explanation of why the committee made the recommendation for research, see the rationale section on diagnosis.

Full details of the evidence and the committee's discussion are in evidence review C: diagnosis of diabetes.


Source guidance details

Comes from guidance
Type 1 diabetes in adults: diagnosis and management
Number
NG17
Date issued
August 2015

Other details

Is this a recommendation for the use of a technology only in the context of research? No  
Is it a recommendation that suggests collection of data or the establishment of a register?   No  
Last Reviewed 31/03/2022